Showing results (61-70 of 67) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Neuro-Oncology|March 10, 2016
Classification based on mutations of TERT promoter and IDH characterizes subtypes in grade II/III gliomasPei Yang, Jinquan Cai, Wei Yan, et al.Cancer Communications (London, England)|March 13, 2026
Vebreltinib for Previously Treated Astrocytoma, <i>IDH</i>-Mutant, Grade 4, and Glioblastoma, <i>IDH</i> Wild-Type with <i>PTPRZ1-MET</i> Fusion Gene: A Multicenter, Phase III Randomized, Open-Label TrialZhaoshi Bao, Yake Xue, Yanhui Liu, et al.Neuro-Oncology|February 17, 2025
Unveiling spatial heterogeneity in medulloblastoma: a multi-omics analysis of cellular state and geographical organizationJiankang Li, Hailong Liu, Ziwei Wang, et al.Cancer Letters|February 25, 2026
Clinical practice guidelines for the diagnosis and treatment of diffuse glioma-related epilepsy:2025 updateShuli Liang, Xing Fan, Suhui Kuang, et al.Cancer Letters|March 12, 2016
CGCG clinical practice guidelines for the management of adult diffuse gliomasTao Jiang, Ying Mao, Wenbin Ma, et al.Cancer Letters|November 9, 2020
Clinical practice guidelines for the management of adult diffuse gliomasTao Jiang, Do-Hyun Nam, Zvi Ram, et al.Cancer Letters|December 3, 2025
Updated clinical practice guidelines for the management of adult diffuse gliomasTao Jiang, Do-Hyun Nam, Zvi Ram, et al.Pageof 7